How Long Until Treatment Works? A 90-Day Timeline

You started treatment two weeks ago, and some days seem easier while other days feel the same. You want to know whether to keep going, call the office, or ask for a different plan. The first three months can have useful checkpoints. They cannot promise a date when you will feel well.

How long does mental health treatment take to work?

Antidepressants often take four to eight weeks to show benefit, while therapy and other medicines follow different schedules, so use the first ninety days for planned reviews of symptoms, daily life, and side effects, and contact your care team sooner for worsening symptoms or safety concerns.1

Before week one: choose what you will measure

Pick two changes that would matter in your life, because “feel better” may be too broad to guide a treatment review. Try “get through a work shift without leaving early” or “eat dinner with my family three nights this week.” These are examples, not targets everyone should meet.

Then ask your clinician which symptom scale fits. The PHQ-9 tracks depression symptoms; other conditions need other tools. A score can help you describe change, but it cannot replace a conversation about your life.7

Write down what things look like now, including your sleep, the tasks that seem hardest, and symptoms that were present before the medicine. If you already had low desire, nausea, or poor sleep, note that too. You can bring this short record to the first review. The guide on what to tell your psychiatrist at the first visit covers the history that belongs beside it.

Think of the marks on a stake beside a growing plant. The marks help you see change that is hard to notice each day. They do not force growth on a schedule. Your notes serve the same purpose.

Ask three planning questions before you leave: “When is our next review? What should prompt an earlier call? Who responds if you are away?” If you are still choosing care, use the guide to finding a psychiatric provider.

Zoom

The first twelve weeks: a review schedule

This table is a discussion guide. Your clinician may arrange more frequent visits. Count treatment from when it actually began, then record any changes or gaps.78

The table does not set dose changes. Those depend on the drug, diagnosis, time at a useful dose, side effects, and your preferences.715

Weeks one and two: check safety and early change

Some antidepressant benefits may appear before mood lifts. Sleep, appetite, or energy can change first. Early nausea or headache may also occur, and some side effects ease with time.1

Do not label every change as progress. Sleeping less while feeling driven, unusually powerful, or unable to slow down needs a prompt call. It may signal a mood shift that changes the treatment plan.118

NICE recommends an initial antidepressant review usually within two weeks, or within one week for adults aged 18 to 25 or when suicide risk is a concern. That schedule is a minimum planning guide, not a reason to wait with a new problem.8

A meta-analysis found that improvement at two weeks helped predict later response. It did not show that everyone without early change should switch at day fourteen. Early improvement is a clue; lack of it calls for closer attention.2

Week four: ask whether the plan is moving

CANMAT advises considering a clinician-led change when early improvement is absent by about four weeks. NICE also calls for review when there is no response after four weeks at a recognized treatment dose. Neither rule means you should raise a dose yourself.78

Ask what could explain the lack of change. Was the medicine available? Were side effects making it hard to follow the plan? Has therapy actually started? Are sleep problems, substance use, medical illness, or a different diagnosis part of the picture?815

Be plain about practical barriers. “I could only fill it last Tuesday” changes the timeline. “I missed two sessions because I had no ride” changes what treatment you have received. The plan needs those facts, not a perfect attendance story.

A dose increase is one possible choice. So are changing a medicine, changing the therapy, or adding treatment. A higher dose is not always more helpful and can bring more side effects.815

Weeks six and eight: tell response from remission

Clinicians often use response to mean a large drop in symptoms. In depression studies, that commonly means a reduction of at least half. Remission means symptoms have fallen into a low range. A person can respond well and still have symptoms that need care.7

In the original STAR*D first treatment step, about one in four to one in three people reached remission, depending on the symptom measure and the analysis. The course lasted up to fourteen weeks.35 Some people who improved needed eight weeks or longer. That is a reason to assess steady gains, not a reason to keep an ineffective plan forever.34

STAR*D’s much quoted cumulative success rate across several treatment steps is disputed. A published reanalysis and a reply from the original investigators disagree about how outcomes should be counted. Those overall figures are not your odds of being well by day ninety.5617

For the detailed early antidepressant experience, read The Waiting Game. At this point, bring the conversation back to your own trend: better, unchanged, worse, or mixed.

Week twelve: make the next plan explicit

Twelve weeks is a review point, not a deadline for recovery. If treatment helps, ask which symptoms still limit your life. If you feel well, discuss how to protect that gain. If it is not helping, ask for a clear reassessment and next step.715

Ask the clinician for a copy of the next plan in a few lines: what you are trying, why, what you will track, and when you will talk again. You should not have to leave wondering whether the plan is “wait and see” without an end date.

When several appropriate treatments have not helped, a more detailed review is needed. The site’s guide to treatment-resistant depression explains that discussion.

What counts as a fair treatment trial?

A treatment trial includes more than the date on a prescription bottle. The clinician needs to know how long you received the treatment at a dose or level likely to help, whether you could follow the plan, and whether side effects limited it. VA/DoD guidance describes an adequate initial medication course as six to twelve weeks, including enough time at a tolerated treatment dose. Your prescriber applies that guidance to the specific medicine and your health.15

Consider two people whose first visit was eight weeks ago. One began therapy that week and attended each planned session; the other spent six weeks waiting for an opening. They have reached the same calendar date but received different amounts of care. This example explains why you should count sessions and treatment access alongside weeks, without judging yourself for a delay you could not control.

At a review, name which parts of treatment were possible and which were not. If a copay meant skipping visits, ask what lower-cost plan could still meet your needs. If a side effect kept you from following the prescription, describe it directly. Ask the clinician to record those limits before calling a treatment unsuccessful, so the next choice reflects what you actually received.

How long do other treatments take to work?

A friend’s treatment schedule may have little to do with yours. Ask about the first likely sign of benefit and the length of a fair trial for your exact treatment. If you are still weighing options, see therapy, medication, or both.

Structured therapy: NICE lists courses such as eight sessions for some depression therapies and sixteen for others, depending on severity and approach. These are course lengths, not promises of remission by the last session.8 Ask what the sessions and practice between visits are meant to change.

ADHD medicines: Methylphenidate can act within the day, once an effective dose is found. Finding that dose can take weeks. Atomoxetine works more gradually; some change may appear early, with fuller benefit taking weeks. Other non-stimulants have their own schedules.1314 See the ADHD medication comparison.

Buspirone: Its fuller anxiety benefit usually takes three to four weeks of regular prescribed use. It is not an as-needed rescue medicine.1

Mood stabilizers: The drug and the goal matter. Lithium can take weeks or longer to show its full benefit. Lamotrigine requires slow dose increases over weeks; it is not an acute mania treatment.1116 Ask how symptoms will be managed while the longer plan is taking effect.

Antipsychotic medicines: Agitation and hallucinations may ease in days, while other symptoms can take several weeks. Full benefit may take up to about six weeks, and sometimes longer. Early sedation alone is not the same as recovery.1

CBT-I for insomnia: A typical course lasts six to eight weeks. The work includes more than general sleep tips.10

TMS: A conventional course often involves weekday sessions over four to six weeks. Accelerated protocols have different schedules. The number of days does not guarantee benefit.19 Read the TMS guide.

Esketamine: Depression symptoms may improve rapidly in some patients, but ongoing assessment is still needed. Its label calls for a benefit review after the initial four-week phase. It has not been shown to prevent suicide or replace needed hospital care.12

How do you track progress between visits?

Measurement-based care means checking symptoms with a standard tool, reviewing the results, and using them in treatment decisions. A review of seven trials found better remission rates with this approach, though the studies had limits and findings for response were less clear. Filling out a form alone is not the treatment.9

Try this weekly note. Keep the same format and bring it to your visit:

• Week and date: ___
• Symptom scale and score, if assigned: ___
• One thing I could do more easily: ___
• One thing that remains hard: ___
• Sleep and new side effects: ___
• Missed treatment or access problems: ___
• My main question for the next review: ___

A rough note is enough, so you do not need an app or a detailed journal to take part in your treatment review. If tracking makes you check yourself all day, ask for a simpler plan. If forms are hard to read, ask to review the questions together.

Bring changes in sex, appetite, weight, or feeling emotionally flat to the review too. Some effects can persist instead of fading after the first weeks. At each review, the clinician should weigh those effects alongside symptom relief, daily function, and your own treatment priorities.8 The antidepressant side-effect guide covers that discussion. If worry about side effects is making it hard to continue, read Afraid of Psychiatric Medication? Start Here.

When to get help now

Contact the care team promptly for worsening mood, new suicidal thoughts, severe restlessness, or signs of mania such as much less need for sleep with unusual energy or risky behavior. Do not treat these as routine signs that a medicine is starting to work.118

A new rash while taking lamotrigine needs urgent medical advice, and rash with blisters, fever, or mouth sores needs emergency evaluation.11 Fever with confusion, marked agitation, and muscle stiffness or twitching can signal a serious drug reaction and also needs emergency care.1

If you cannot stay safe, seek immediate help. Do not wait for the tracker, the next appointment, or day ninety. Use the urgent mental health care guide. For earlier concerns about whether care is needed, see when to ask for psychiatric help.

Key takeaways

• Early improvement is useful information, not proof of full recovery.2
• Calendar weeks and time on an adequate treatment are different.715
• Side effects and daily function belong beside symptom scores.7
• A plan that is not helping deserves a review, not endless waiting.815
• Call sooner for new safety concerns.111

Frequently asked questions

Can an antidepressant help in the first week?

Some symptoms can change early. That does not establish full response or remission. Keep the planned review and report new problems as well as gains.12

Does no improvement at two weeks mean it will fail?

No. Early change can help predict later benefit, but it is not a pass-or-fail test. Your clinician should review the dose, side effects, and treatment course before deciding what comes next.27

Should I feel well by ninety days?

There is no universal deadline. By that point, you should have a clear review of progress and a next plan. Ongoing symptoms deserve attention even when some parts of life have improved.715

Should I change my dose if progress stops?

Bring the change to your prescriber. A dose change is only one option, and more is not always better. Do not start, stop, or change a dose on your own.18

Related reading on NP FADY

• When a Loved One Refuses Mental Health Help
• Afraid of Psychiatric Medication? Start Here
• Therapy, Medication, or Both?
• The Waiting Game: why antidepressants take time and how to make the first six weeks count

References

1. National Institute of Mental Health. Mental health medications.

2. Szegedi A, Jansen WT, van Willigenburg APP, van der Meulen E, Stassen HH, Thase ME. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry. 2009;70(3):344-353.

3. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. PMID 16390886.

4. National Institute of Mental Health. Historical STAR*D results: all medication levels. 2006.

5. Pigott HE, Kim T, Xu C, Kirsch I, Amsterdam J. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol. BMJ Open. 2023;13(7):e063095. doi:10.1136/bmjopen-2022-063095.

6. Rush AJ, Trivedi M, Fava M, Thase M, Wisniewski S. The STAR*D Data Remain Strong: Reply to Pigott et al. Am J Psychiatry. 2023;180(12):919-920. doi:10.1176/appi.ajp.20230869.

7. Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024;69(9):641-687. doi:10.1177/07067437241245384.

8. National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222).

9. Zhu M, Hong RH, Yang T, et al. The efficacy of measurement-based care for depressive disorders: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2021;82(5):21r14034.

10. National Heart, Lung, and Blood Institute. Insomnia treatment.

11. LAMICTAL (lamotrigine). Prescribing information and Medication Guide. GlaxoSmithKline. Verified September 18, 2026.

12. SPRAVATO (esketamine). Prescribing information, revised March 2026. Verified September 18, 2026.

13. NHS. Methylphenidate for adults: common questions.

14. MedlinePlus. Atomoxetine.

15. Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder, version 4.0. 2022. Adequate-trial definition: Recommendation 16 discussion, page 45.

16. NHS. Lithium: common questions.

17. Pigott HE, Kim TT, Xu C, et al. STAR*D’s Cumulative Remission Rate and Why It Still Matters. Psychiatric Times. March 6, 2024. Commentary by the reanalysis authors.

18. ZOLOFT (sertraline hydrochloride). Prescribing information and Medication Guide, revised August 2023. DailyMed, National Library of Medicine. Verified September 18, 2026.

19. National Institute of Mental Health. Brain stimulation therapies. Last reviewed March 2024.

This article is for education and is not a substitute for care from a qualified health professional. Do not start, stop, or change medication without your prescriber’s guidance. Evidence last checked September 18, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.